{"gene":"NOX4","run_date":"2026-04-29T11:37:57","timeline":{"discoveries":[{"year":2003,"finding":"Nox4-based NADPH oxidase mediates angiotensin II-induced ROS generation and downstream Akt/PKB activation and protein synthesis in mesangial cells, acting downstream of Rac1 and arachidonic acid signaling","method":"Antisense oligonucleotide knockdown of Nox4, dominant-negative Rac1, NADPH oxidase activity assay, Akt phosphorylation measurement, protein synthesis assay","journal":"American journal of physiology. Renal physiology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (AS knockdown, DN-Rac1, functional assays) in single study","pmids":["12842860"],"is_preprint":false},{"year":2005,"finding":"Nox4 is the major source of NADPH-dependent ROS in diabetic kidney, and Nox4-derived ROS mediate renal hypertrophy and fibronectin expression via Akt/PKB and ERK1/2 activation","method":"Antisense oligonucleotide knockdown in vivo and in vitro, NADPH oxidase activity assay, glomerular hypertrophy measurement, fibronectin western blot, kinase phosphorylation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — in vivo and in vitro knockdown with multiple functional readouts, >400 citations indicating replication","pmids":["16135519"],"is_preprint":false},{"year":2009,"finding":"Nox4 localizes to mitochondria in mesangial cells and kidney cortex, and mitochondrial Nox4 is a functional source of NADPH oxidase-dependent superoxide generation; siRNA knockdown of Nox4 reduces mitochondrial NADPH oxidase activity and blocks glucose-induced mitochondrial superoxide","method":"Subcellular fractionation, immunofluorescence confocal microscopy with MitoTracker, siRNA knockdown, NADPH oxidase activity assay in purified mitochondria","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal localization methods plus functional validation with siRNA","pmids":["19706525"],"is_preprint":false},{"year":2009,"finding":"The cytosolic tail of Nox4 confers constitutive activity, while the N-terminal region determines subcellular localization (ER vs. plasma membrane) and the type of ROS released (H2O2 vs. superoxide); Nox4 colocalizes with ER marker proteins","method":"Chimeric Nox1/Nox4 constructs expressed in HEK293 cells, TIRF microscopy, ROS measurement, N-terminal signal peptide swap experiments","journal":"Antioxidants & redox signaling","confidence":"High","confidence_rationale":"Tier 1 — domain-swap mutagenesis plus live-cell localization imaging with functional ROS output","pmids":["19061439"],"is_preprint":false},{"year":2008,"finding":"Nox4 acts as a switch from insulin-induced proliferation to differentiation in preadipocytes by controlling MAP kinase phosphatase-1 (MKP-1) expression, which limits ERK1/2 signaling; downregulation of Nox4 promotes ERK1/2-dependent proliferation and inhibits differentiation via IRS-1 phosphorylation at Ser612","method":"siRNA knockdown, Nox4 overexpression, MKP-1 siRNA and overexpression, ERK1/2 inhibition, IRS-1 phosphorylation assays in human and mouse preadipocytes","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal gain/loss-of-function with multiple pathway readouts in two cell types","pmids":["19057021"],"is_preprint":false},{"year":2006,"finding":"NOX4 interacts with p22phox (shown by bimolecular fluorescent complementation) and co-localizes with the endoplasmic reticulum marker calreticulin in endothelial cells; NOX4 contributes equally with NOX2 to endothelial ROS production and proliferation","method":"Bimolecular fluorescent complementation, colocalization with ER marker, siRNA knockdown, ROS measurement, proliferation assays","journal":"Antioxidants & redox signaling","confidence":"High","confidence_rationale":"Tier 2 — protein-protein interaction (BiFC) plus colocalization and functional knockdown","pmids":["16987004"],"is_preprint":false},{"year":2016,"finding":"Nox4 is induced downstream of ATF4, binds to the PP1-targeting subunit GADD34 at the endoplasmic reticulum, and inhibits PP1 via oxidation of the PP1 metal center (not thiol oxidation), thereby sustaining eIF2α phosphorylation and ATF4 levels to promote cell survival during stress","method":"Co-immunoprecipitation (Nox4–GADD34), PP1 activity assay, eIF2α phosphorylation measurement, mutagenesis, ER fractionation, heart ischemia-reperfusion and kidney injury in vivo models","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 — biochemical reconstitution of PP1 inhibition mechanism, Co-IP, metal-center oxidation identified, in vivo validation","pmids":["26742780"],"is_preprint":false},{"year":2020,"finding":"Stress-induced Nox4 localizes to ER-mitochondria contact sites (MAMs) and inhibits calcium transfer through InsP3 receptors by augmenting Akt-dependent phosphorylation of InsP3R, thereby preventing mitochondrial permeability transition-dependent necrosis; limits infarct size in ischemia-reperfusion","method":"MAM fractionation, co-immunoprecipitation, InsP3R phosphorylation assay, calcium flux measurement, mPT assay, Nox4 KO mice, cardiomyocyte and neuron models","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal biochemical methods plus in vivo KO model","pmids":["33001475"],"is_preprint":false},{"year":2016,"finding":"FYN tyrosine kinase interacts with the C-terminal domain of NOX4, co-localizes in perinuclear mitochondria/ER/nuclear fractions, and directly phosphorylates NOX4 at tyrosine 566 to negatively regulate NOX4-induced ROS production and apoptosis; FYN KO mice show exaggerated cardiac remodeling rescued by Nox4 deletion","method":"Co-immunoprecipitation, site-directed mutagenesis (Y566), ROS measurement, apoptosis assay, FYN KO and Nox4 KO epistasis in mice with transverse aortic constriction","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1–2 — direct phosphorylation site identified by mutagenesis, Co-IP, genetic epistasis in vivo","pmids":["27525436"],"is_preprint":false},{"year":2011,"finding":"Nox4 activates the Nrf2-regulated antioxidant pathway in cardiomyocytes, increasing expression of antioxidant/detoxifying genes and elevating GSH levels; these effects are abolished in an Nrf2-null genetic background","method":"Transgenic Nox4 overexpression in mouse heart, microarray transcriptomics, Q-PCR, GSH measurement, Nrf2 KO epistasis","journal":"Free radical biology & medicine","confidence":"High","confidence_rationale":"Tier 2 — transgenic OE plus Nrf2 KO epistasis with multiple molecular readouts","pmids":["21554947"],"is_preprint":false},{"year":2013,"finding":"TGF-β1-induced podocyte apoptosis is mediated by selective upregulation of Nox4 (localized to mitochondria) via TGF-β receptor I–Smad2/3 signaling, leading to ROS production, mitochondrial membrane potential loss, and caspase-3 activation","method":"siRNA knockdown (Nox4, Smad2, Smad3), TGF-β receptor inhibitor, Nox inhibitor DPI, mitochondrial membrane potential assay, caspase-3 activation assay, immunofluorescence","journal":"American journal of physiology. Renal physiology","confidence":"High","confidence_rationale":"Tier 2 — multiple siRNA targets defining pathway, plus pharmacological inhibitors and localization","pmids":["24259511"],"is_preprint":false},{"year":2015,"finding":"NOX4 silencing in VHL-deficient renal cell carcinoma cells abrogates invasion, colony formation, and xenograft growth; NOX4 knockdown or superoxide scavenging blocks nuclear accumulation of HIF2α, establishing NOX4 as required for HIF2α nuclear localization and renal tumorigenesis","method":"siRNA knockdown, TEMPOL and catalase/MnSOD overexpression, xenograft model, HIF2α nuclear fractionation, cell invasion and colony assays","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic and pharmacological interventions, in vivo xenograft, mechanistic readout of HIF2α localization","pmids":["24755467"],"is_preprint":false},{"year":2015,"finding":"NOX4 promotes tumour angiogenesis by stabilizing HIF-1α and inducing VEGF-A, Glut1, and adrenomedullin expression; Nox4 knockout mice show 38% reduced tumour vessel density in fibrosarcoma model","method":"Nox4 KO mice (carcinogen-induced fibrosarcoma), CD31 immunostaining, Hif-1α and VEGF expression analysis","journal":"Acta physiologica (Oxford, England)","confidence":"Medium","confidence_rationale":"Tier 2 — clean KO with defined angiogenic phenotype and molecular mechanism, but single study","pmids":["26513738"],"is_preprint":false},{"year":2015,"finding":"NOX4 in endothelial cells produces H2O2 rather than superoxide, and has anti-atherosclerotic function; endothelial-specific (but not macrophage) Nox4 deletion increases macrophage adhesion and atherosclerosis in ApoE-/- mice","method":"Tamoxifen-induced Nox4 KO crossed with ApoE-/- mice, cell-type-specific KO (endothelial vs. macrophage), atherosclerosis measurement, macrophage adhesion assay","journal":"European heart journal","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific KO with defined mechanistic readout; replicated across two atherosclerosis models","pmids":["26385958"],"is_preprint":false},{"year":2017,"finding":"Nox4-derived H2O2 activates Nox2 to increase mitochondrial ROS via p66Shc phosphorylation at Ser36, thereby enhancing VEGFR2 signaling and angiogenesis in endothelial cells (ROS-induced ROS release mechanism)","method":"Redox-sensitive RoGFP biosensors (cytosol- and mitochondria-targeted), siRNA knockdown of Nox4/Nox2, Nox4 overexpression, p66Shc(S36A) mutant, VEGFR2 phosphorylation assay, migration/proliferation assays","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 1–2 — real-time biosensor imaging plus genetic and mutagenesis approaches defining the pathway","pmids":["28424170"],"is_preprint":false},{"year":2015,"finding":"NOX4-derived ROS inactivate protein tyrosine phosphatases (PTPs) and are required for all insulin signaling through AKT and ERK in hepatocytes; knockdown or inhibition of NOX4 reproduces the pattern of pathway-selective insulin resistance seen in diabetic db/db mice","method":"siRNA knockdown in cultured hepatocytes, pharmacological NOX4 inhibition, AKT Thr308/Ser473 phosphorylation assay, insulin injection in db/db mice","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 — knockdown recapitulates in vivo phenotype with multiple pathway readouts","pmids":["22328777"],"is_preprint":false},{"year":2015,"finding":"NOX4-driven ROS inactivate the protein tyrosine phosphatase DEP-1/PTPRJ in FLT3ITD-positive AML cells; NOX4 expression is driven by STAT5 transcriptional activation of the NOX4 promoter downstream of FLT3ITD, and NOX4 knockdown restores PTP activity and attenuates FLT3ITD-driven transformation","method":"NOX4 mRNA/protein measurement, STAT5 promoter activation assay, NOX4 knockdown, PTP activity assay, Nox4 KO hematopoietic progenitor transformation assay, in vivo mouse leukemia models","journal":"Leukemia","confidence":"High","confidence_rationale":"Tier 2 — PTP activity reconstitution, STAT5-promoter link, Nox4 KO epistasis in vitro and in vivo","pmids":["26308771"],"is_preprint":false},{"year":2019,"finding":"Inositol 1,3,4,5-tetrakisphosphate (IP4), product of ITPKB, inhibits NOX4 by competing with NADPH for binding to NOX4, thereby reducing cisplatin-induced ROS and promoting cisplatin resistance","method":"ITPKB RNAi screen, IP4 competition binding assay with NADPH and NOX4, NOX4 activity assay, patient-derived xenografts, ITPKB inhibitor","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1 — in vitro competitive binding assay identifying IP4 as NOX4 cofactor competitor, plus in vivo PDX validation","pmids":["31081803"],"is_preprint":false},{"year":2016,"finding":"TGF-β-induced NOX4 expression is required for SMAD phosphorylation and myofibroblast differentiation in lung fibroblasts; metformin activates AMPK to inhibit TGF-β-induced NOX4 expression, blocking fibrogenesis","method":"NOX4 siRNA knockdown, N-acetylcysteine, AMPK activation by metformin, SMAD phosphorylation assay, bleomycin-induced lung fibrosis mouse model","journal":"Respiratory research","confidence":"High","confidence_rationale":"Tier 2 — NOX4 siRNA places NOX4 upstream of SMAD signaling, confirmed in vivo","pmids":["27576730"],"is_preprint":false},{"year":2018,"finding":"NOX4-derived H2O2 stimulates TRPC6-dependent calcium influx in podocytes; genetic ablation of Nox4 reduces basal intracellular Ca2+ and blunts angiotensin II-elicited calcium flux, protecting against diabetic kidney disease","method":"SSNox4-/- rats, TRPC6 KO and TRPC5/6 double-KO mice, live calcium imaging in freshly isolated glomeruli, H2O2 stimulation, electrophysiology, electron microscopy","journal":"Journal of the American Society of Nephrology : JASN","confidence":"High","confidence_rationale":"Tier 1–2 — multiple genetic KO models, live calcium biosensor imaging, electrophysiology","pmids":["29793963"],"is_preprint":false},{"year":2017,"finding":"In PDAC, NOX4 activity accelerates oxidation of NADH and supports glycolysis by generating NAD+ for GAPDH-mediated glycolytic reactions; NOX4 is transcriptionally induced through p16-Rb-E2F pathway and requires p22phox (upregulated by KrasG12V-NF-κB) for its catalytic activity","method":"Gene expression profiling, NOX4 activity assay (NADH oxidation), p22phox Co-IP/expression, NF-κB reporter assay, E2F ChIP, glycolytic flux measurement in PDAC cell lines and patient specimens","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1–2 — biochemical activity assay defining NAD+ generation function, multiple regulatory pathway dissections","pmids":["28232723"],"is_preprint":false},{"year":2021,"finding":"Skeletal muscle NOX4, induced by exercise, generates H2O2 that activates NFE2L2-mediated antioxidant defense; NOX4 deletion in skeletal muscle compromises antioxidant defense and causes insulin resistance in aging and obesity, which is corrected by GPX-1 deletion or NFE2L2 agonist","method":"Muscle-specific Nox4 KO mice, exercise testing, ROS measurement, NFE2L2 target gene expression, insulin tolerance, GPX-1 KO epistasis, NFE2L2 agonist treatment","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 — tissue-specific KO with genetic epistasis (GPX-1 KO) and pharmacological rescue","pmids":["34910515"],"is_preprint":false},{"year":2016,"finding":"Nox4 promotes smooth muscle cell neointimal hyperplasia by upregulating thrombospondin 1 (TSP1), which drives SMC proliferation and migration; Nox4 dominant-negative mutation or siRNA knockdown reduces TSP1 expression and neointima formation after wire injury","method":"SM22α-driven Nox4 dominant-negative (P437H) transgenic mice, wire injury model, siRNA knockdown, TSP1 mRNA/protein, SMC proliferation and migration assays","journal":"Journal of molecular and cellular cardiology","confidence":"High","confidence_rationale":"Tier 2 — in vivo transgenic model plus siRNA confirmation identifying TSP1 as downstream effector","pmids":["26582463"],"is_preprint":false},{"year":2013,"finding":"ADAM17 activation by hyperglycemia increases Nox4 expression and NADPH oxidase activity in kidney cortex, establishing Nox4 as downstream of ADAM17 in extracellular matrix accumulation in diabetic nephropathy","method":"ADAM17 inhibitor (TMI-005), ADAM17 siRNA, Nox4 expression and NADPH oxidase activity measurement, fibronectin/collagen expression in OVE26 diabetic mice and proximal tubular cells","journal":"American journal of physiology. Renal physiology","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological and genetic inhibition places Nox4 downstream of ADAM17, single lab","pmids":["23678045"],"is_preprint":false},{"year":2016,"finding":"NOX4-derived ROS suppress Rho GTPase (RhoC) and Cdc42 expression and downstream actomyosin contractility in hepatocellular carcinoma cells, maintaining epithelial characteristics and suppressing amoeboid invasion","method":"NOX4 siRNA knockdown and overexpression, Rho/Cdc42 expression, actomyosin contractility assay, 3D invasion assay, Nox4-deficient HCC patient correlation","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal gain/loss-of-function with defined molecular readouts, single lab","pmids":["27941881"],"is_preprint":false},{"year":2011,"finding":"NOX4 and urotensin-II activate FoxO3a via NOX4-dependent JNK phosphorylation and 14-3-3 phosphorylation, reducing FoxO3a–14-3-3 interaction and enabling MMP-2 transcription to promote vascular smooth muscle cell proliferation and migration","method":"NOX4 siRNA, FoxO3a knockdown, FoxO3a-/- mice, MMP2 inhibitor, JNK phosphorylation, 14-3-3 co-immunoprecipitation","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — genetic KO epistasis plus Co-IP defining mechanism, multiple orthogonal approaches","pmids":["21965295"],"is_preprint":false},{"year":2021,"finding":"NOX4 upregulation by RANKL activates ROS/PERK/eIF-2α/ATF4 pathway to promote autophagy and osteoclastogenesis; Nox4 inhibition or shRNA knockdown attenuates RANKL-induced autophagy and osteoclast formation","method":"Nox4 shRNA, 5-O-methyl quercetin Nox4 inhibitor, PERK inhibitor (GSK2606414), ROS scavenger, ATF4/eIF-2α phosphorylation assay, autophagy measurement, osteoclastogenesis assay","journal":"Frontiers in pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple inhibitors and shRNA defining pathway; single lab","pmids":["34650437"],"is_preprint":false},{"year":2021,"finding":"NOX4 global or neuronal knockdown in mice reduces pathological tau accumulation and improves macroautophagy flux via the autophagy-lysosomal pathway, preventing cognitive decline in a tauopathy model","method":"Global Nox4 KO, neuronal-targeted Nox4 shRNA (AAV-TauP301L model), autophagy flux measurement, tau immunostaining, cognitive behavioral testing","journal":"Redox biology","confidence":"High","confidence_rationale":"Tier 2 — two genetic approaches (KO and neuron-specific KD) with functional epistasis and in vivo cognitive readout","pmids":["34922273"],"is_preprint":false},{"year":2019,"finding":"Tachypacing-induced CD44 signaling directly associates with NOX4 (co-immunoprecipitation documented), increasing NOX4 expression and oxidative stress leading to CaMKII oxidation and ryanodine receptor phosphorylation, contributing to atrial fibrillation","method":"Co-immunoprecipitation (CD44–NOX4), HAS/HA/CD44 pathway blockade, CD44-/- mice, Ca2+ spark measurement, ox-CaMKII and p-RyR2 assays","journal":"Journal of molecular and cellular cardiology","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP plus CD44 KO mice with functional calcium readouts; single lab","pmids":["31419440"],"is_preprint":false},{"year":2021,"finding":"CYB5R3 interacts with NOX4 at the mitochondrial outer membrane (confirmed by APEX2-EM, proximity ligation, and Co-localization by super-resolution microscopy), and CYB5R3 activity and membrane translocation are required for optimal H2O2 generation by NOX4 via coenzyme Q; endothelial CYB5R3 loss exacerbates NOX4-dependent inflammatory activation","method":"APEX2-based electron microscopy, proximity biotinylation, proximity ligation assay, super-resolution confocal microscopy, Cyb5r3 KO mice, siRNA double-knockdown (CYB5R3+NOX4), COQ6 KO cells","journal":"Redox biology","confidence":"High","confidence_rationale":"Tier 1–2 — multiple structural/proximity methods establishing protein interaction plus genetic epistasis defining functional consequence","pmids":["34656824"],"is_preprint":false},{"year":2022,"finding":"PKCα directly binds NOX4 and mediates TRPM7-dependent chondrocyte ferroptosis; TRPM7 channel inhibition reduces intracellular Ca2+, suppresses PKCα-NOX4 interaction, and attenuates ferroptosis in rheumatoid arthritis chondrocytes","method":"Co-immunoprecipitation (PKCα–NOX4), TRPM7 knockdown/pharmacological inhibition, calcium imaging, ferroptosis markers (MDA, lipid ROS), AA-rat model, AAV9-TRPM7 silencing","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2–3 — Co-IP identifying PKCα as NOX4 binding partner, plus in vivo AAV gene silencing; single lab","pmids":["35917680"],"is_preprint":false},{"year":2023,"finding":"NOX4 locus contains IRE-like sequences bound and repressed by IRP1; iron loading induces IRP1 dissociation from these sequences, activating NOX4 transcription and increasing lipid peroxidation and ferroptosis in osteoblasts, contributing to osteoporotic bone loss","method":"IRE-like sequence identification in NOX4 locus, IRP1 binding/dissociation assay, iron overload mouse model (Hepc1-/-), ferroptosis inhibitor (Ferr-1), iron chelator (DFO), mitochondrial morphology by electron microscopy","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 — identifies novel transcriptional regulatory element with functional in vivo validation; single study","pmids":["36738798"],"is_preprint":false},{"year":2020,"finding":"Mitochondria-derived ROS activate NFE2L2 which induces NOX4 expression; NOX4-derived H2O2 further amplifies NFE2L2 antioxidant defense; hepatocyte-specific NOX4 deletion reduces antioxidant defense and promotes NASH and fibrosis in obese mice","method":"Hepatocyte-specific Nox4 KO, Nox4 overexpression, ROS measurement, NFE2L2 target gene expression, NASH scoring, mitochondrial ROS imaging","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — tissue-specific KO with overexpression rescue, multiple molecular and histological readouts","pmids":["38060313"],"is_preprint":false},{"year":2022,"finding":"NOX4 deletion in HCC leads to Nrf2 activation that upregulates MYC, which drives mitochondrial dynamics and metabolic reprogramming (increased oxidative metabolism, glycolysis, fatty acid use) to promote HCC progression","method":"Cell-based NOX4 loss/gain of function, proteomics, transcriptomics, metabolomics, in vivo hepatocarcinogenesis in Nox4-deficient mice, human HCC sample analysis","journal":"Hepatology (Baltimore, Md.)","confidence":"High","confidence_rationale":"Tier 2 — multi-omics in complementary experimental models with in vivo validation","pmids":["35920301"],"is_preprint":false},{"year":2021,"finding":"NOX4 promotes glycolysis in thyroid carcinoma via the mROS–HIF1α axis; NOX4 knockdown and p22phox knockout both abolish mitochondrial ROS increase and destabilize HIF1α in hypoxia, reducing glycolysis and cell growth","method":"NOX4 siRNA knockdown, p22phox CRISPR KO, mROS measurement, HIF1α stability assay, glycolytic flux measurement","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — two complementary genetic approaches defining pathway; single lab","pmids":["30367082"],"is_preprint":false},{"year":2024,"finding":"ISG15 promotes NOX4 ISGylation to stabilize the protein; DRD4 activation reduces ISG15 expression, enhancing NOX4 ubiquitination and degradation, thereby counteracting oxidative stress-induced acute kidney injury","method":"Transcriptome sequencing, ISG15 knockdown, ISGylation and ubiquitination assays for NOX4, DRD4 KO mice (IRI and cisplatin models), HK-2 cell oxidative stress","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 — identifies ISGylation as NOX4 stability mechanism with genetic in vivo validation; single lab","pmids":["38354631"],"is_preprint":false},{"year":2020,"finding":"Nox4 regulates PDGF-induced mesenchymal cell migration by generating H2O2 that activates PKB/Akt (but not Erk1/2) via the PI3-kinase pathway; Nox4 siRNA knockdown reduces PDGF-stimulated H2O2, PKB/Akt phosphorylation, and migration in MSC","method":"Nox4 siRNA, real-time H2O2 measurement, PKB/Akt and Erk1/2 phosphorylation assays, migration assay in 3T3 fibroblasts and MSC","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA knockdown with pathway-specific phosphorylation readouts; single lab","pmids":["27110716"],"is_preprint":false},{"year":2018,"finding":"NOX4-derived ROS activate GLI1 (Hedgehog pathway transcription factor) to promote gastric cancer cell proliferation; DPI (ROS inhibitor) and NOX4 knockdown reduce GLI1 expression, and GLI1 overexpression rescues proliferation in NOX4-knockdown cells","method":"NOX4 siRNA, DPI treatment, GLI1 overexpression rescue, proliferation assay, western blot for Cyclin D1/BAX","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 — rescue experiment linking NOX4-ROS to GLI1; single lab","pmids":["29496628"],"is_preprint":false},{"year":2020,"finding":"NOX4-derived ROS regulates epithelial Na+ channel (ENaC) activity in the cortical collecting duct; H2O2 upregulates ENaC, and genetic ablation of Nox4 in Dahl salt-sensitive rats attenuates high-salt-induced ENaC activity increase","method":"SSNox4-/- rat model, electrophysiology (ENaC patch-clamp), H2O2 stimulation, renal H2O2 production measurement","journal":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO with functional electrophysiology; single lab","pmids":["32799394"],"is_preprint":false},{"year":2021,"finding":"In cardiomyocytes, Nox4 is activated downstream of mTORC2/Rictor; siRNA knockdown of Rictor decreases Nox4 and NADPH oxidase activity, restoring podocin levels and reducing podocyte apoptosis in diabetic models","method":"Rictor siRNA and antisense oligonucleotides, Nox4 expression and NADPH oxidase activity, podocin measurement, apoptosis assay, OVE26 diabetic mouse model","journal":"Antioxidants & redox signaling","confidence":"Medium","confidence_rationale":"Tier 2 — genetic epistasis placing mTORC2 upstream of Nox4; in vitro and in vivo","pmids":["27393154"],"is_preprint":false}],"current_model":"NOX4 is a constitutively active, p22phox-dependent NADPH oxidase that localizes primarily to the endoplasmic reticulum (and to ER-mitochondria contact sites and mitochondria in some contexts) and uniquely produces H2O2 rather than superoxide; it regulates diverse cellular processes including survival signaling (via PP1 inhibition at GADD34/ER, Akt-dependent InsP3R phosphorylation at MAMs, and Nrf2-GSH pathway), transcription factor activity (HIF2α nuclear accumulation, FoxO3a, GLI1), ion channel regulation (ENaC, TRPC6-dependent Ca2+ influx), and metabolic adaptation (NAD+ regeneration for glycolysis, NFE2L2-antioxidant defense); its activity is negatively regulated by FYN-mediated tyrosine phosphorylation at Y566 and by IP4 competing for the NADPH binding site, and positively regulated by mTORC2, STAT5, TGF-β/Smad, and iron-responsive IRP1 dissociation from NOX4 promoter IRE-like elements."},"narrative":{"teleology":[{"year":2003,"claim":"Establishing NOX4 as a functional NADPH oxidase in non-phagocytic cells resolved the question of which oxidase generates angiotensin II-induced ROS in mesangial cells, linking it to Akt/PKB activation and protein synthesis.","evidence":"Antisense oligonucleotide knockdown of Nox4 with dominant-negative Rac1 in mesangial cells","pmids":["12842860"],"confidence":"High","gaps":["Rac1 dependence later contested for NOX4","no structural basis for constitutive activity"]},{"year":2005,"claim":"Demonstrating that Nox4 is the major renal NADPH oxidase in diabetic kidney established it as a disease-relevant ROS source mediating hypertrophy and fibrosis via Akt and ERK1/2.","evidence":"In vivo and in vitro antisense knockdown in diabetic mouse kidney with functional readouts","pmids":["16135519"],"confidence":"High","gaps":["mechanism of Nox4 transcriptional induction in diabetes not defined","specificity of antisense oligonucleotides"]},{"year":2006,"claim":"Visualization of the NOX4–p22phox interaction and ER colocalization established that NOX4 forms a heterodimeric oxidase at the endoplasmic reticulum rather than the plasma membrane.","evidence":"Bimolecular fluorescent complementation with ER marker colocalization in endothelial cells","pmids":["16987004"],"confidence":"High","gaps":["stoichiometry of NOX4–p22phox complex unresolved","no structural model of the heterodimer"]},{"year":2009,"claim":"Domain-swap chimeras between Nox1 and Nox4 revealed that the C-terminal dehydrogenase domain confers constitutive activity and H2O2 (rather than superoxide) production, while the N-terminus dictates subcellular targeting, resolving how NOX4 differs functionally from other NOX isoforms.","evidence":"Chimeric Nox1/Nox4 constructs in HEK293 cells with TIRF microscopy and ROS measurement; separately, mitochondrial localization confirmed by subcellular fractionation and confocal microscopy in mesangial cells","pmids":["19061439","19706525"],"confidence":"High","gaps":["structural basis for H2O2 vs. superoxide selectivity unclear","whether mitochondrial localization reflects outer membrane vs. matrix association"]},{"year":2011,"claim":"Identification of NOX4 as an activator of the Nrf2 antioxidant pathway in cardiomyocytes and of FoxO3a via JNK-dependent 14-3-3 phosphorylation in vascular smooth muscle revealed that NOX4-derived ROS engage specific transcription factor circuits rather than causing indiscriminate oxidative damage.","evidence":"Transgenic Nox4 overexpression with Nrf2 KO epistasis in mouse heart; NOX4 siRNA with FoxO3a KO mice and JNK/14-3-3 Co-IP in VSMCs","pmids":["21554947","21965295"],"confidence":"High","gaps":["direct oxidative target linking NOX4 to Nrf2 activation not identified","whether FoxO3a regulation is cell-type-specific"]},{"year":2015,"claim":"A series of studies established NOX4's dual role in cancer and vascular biology: NOX4-derived ROS stabilize HIF-1α/HIF-2α to promote tumor angiogenesis and renal carcinoma, inactivate protein tyrosine phosphatases to potentiate insulin signaling in hepatocytes, and confer anti-atherosclerotic protection in endothelial cells, demonstrating context-dependent pro- and anti-pathological functions.","evidence":"Endothelial-specific Nox4 KO in ApoE−/− mice; NOX4 siRNA in VHL-deficient RCC with xenograft; Nox4 KO in carcinogen-induced fibrosarcoma; NOX4 knockdown in hepatocytes with insulin signaling readout; STAT5-driven NOX4 expression in FLT3-ITD AML","pmids":["26385958","24755467","26513738","22328777","26308771"],"confidence":"High","gaps":["molecular identity of the oxidized PTPs varies by cell context and is incompletely catalogued","mechanism of HIF-2α nuclear import regulation by ROS unknown"]},{"year":2016,"claim":"Discovery that NOX4 binds GADD34 at the ER and inhibits PP1 via oxidation of the PP1 metal center (not cysteine thiols) provided the first direct enzymatic substrate mechanism for NOX4-derived H2O2, explaining how it sustains eIF2α phosphorylation and ATF4-dependent survival during stress.","evidence":"Co-immunoprecipitation of Nox4–GADD34, PP1 activity assay with metal-center oxidation mechanism, in vivo ischemia-reperfusion models","pmids":["26742780"],"confidence":"High","gaps":["whether metal-center oxidation generalizes to other PP1 holoenzyme contexts","no crystal structure of NOX4–GADD34–PP1 ternary complex"]},{"year":2016,"claim":"Identification of FYN as a direct NOX4 kinase at Y566 that negatively regulates ROS production, with genetic epistasis in FYN KO/Nox4 KO mice, established the first post-translational negative regulatory mechanism for NOX4 catalytic output.","evidence":"Co-IP, Y566 site-directed mutagenesis, FYN KO and Nox4 KO epistasis in transverse aortic constriction model","pmids":["27525436"],"confidence":"High","gaps":["whether other Src-family kinases also phosphorylate Y566","structural consequence of Y566 phosphorylation on dehydrogenase domain"]},{"year":2017,"claim":"Demonstration that NOX4 oxidizes NADH to regenerate NAD+ for GAPDH-dependent glycolysis in pancreatic cancer revealed an unexpected metabolic function beyond canonical ROS signaling, with transcriptional regulation through p16-Rb-E2F and p22phox upregulation via KrasG12V–NF-κB.","evidence":"NADH oxidation assay, glycolytic flux measurement, E2F ChIP, p22phox Co-IP in PDAC cell lines and patient specimens","pmids":["28232723"],"confidence":"High","gaps":["relative contribution of NAD+ regeneration vs. H2O2 signaling to PDAC phenotype unclear","whether NOX4-mediated NAD+ regeneration operates in non-cancer contexts"]},{"year":2018,"claim":"NOX4-derived H2O2 was shown to activate TRPC6-dependent calcium influx in podocytes, defining a non-transcriptional ion-channel regulatory function of NOX4 relevant to diabetic kidney disease.","evidence":"SSNox4−/− rats combined with TRPC6 KO and TRPC5/6 double-KO mice, live calcium imaging, electrophysiology","pmids":["29793963"],"confidence":"High","gaps":["direct molecular target on TRPC6 oxidized by H2O2 not identified","whether ENaC regulation (separately shown) involves the same mechanism"]},{"year":2019,"claim":"Discovery that IP4 inhibits NOX4 by competing with NADPH for its binding site identified a novel endogenous small-molecule mechanism for NOX4 regulation and explained ITPKB-dependent cisplatin resistance.","evidence":"In vitro competitive binding assay (IP4 vs. NADPH on NOX4), patient-derived xenografts, ITPKB inhibitor","pmids":["31081803"],"confidence":"High","gaps":["structural basis for IP4–NADPH competition not resolved","whether other inositol phosphates also regulate NOX4"]},{"year":2020,"claim":"Localization of stress-induced NOX4 to ER–mitochondria contact sites (MAMs) and demonstration that it inhibits InsP3R-mediated calcium transfer via Akt-dependent phosphorylation established a cytoprotective mechanism at the ER–mitochondria interface limiting necrotic cell death.","evidence":"MAM fractionation, InsP3R phosphorylation assay, calcium flux measurement, mPT assay, Nox4 KO mice in ischemia-reperfusion","pmids":["33001475"],"confidence":"High","gaps":["how NOX4 is specifically recruited to MAMs under stress is unknown","which Akt isoform mediates InsP3R phosphorylation downstream of NOX4"]},{"year":2021,"claim":"Tissue-specific knockout studies in skeletal muscle and hepatocytes, combined with CYB5R3 interaction mapping, revealed that NOX4 is a central node in the NFE2L2-mediated antioxidant defense that prevents insulin resistance and NASH, and that CYB5R3 cooperates with NOX4 at the mitochondrial outer membrane via coenzyme Q for optimal H2O2 generation.","evidence":"Muscle-specific and hepatocyte-specific Nox4 KO mice, GPX-1 KO epistasis, NFE2L2 agonist rescue; APEX2-EM, proximity ligation, super-resolution microscopy for CYB5R3–NOX4 interaction, Cyb5r3 KO mice","pmids":["34910515","38060313","34656824"],"confidence":"High","gaps":["whether CYB5R3 donates electrons directly to NOX4 or acts indirectly through CoQ pool","mechanism by which NOX4-derived H2O2 activates NFE2L2 (direct Keap1 oxidation vs. intermediary)"]},{"year":2023,"claim":"Identification of IRE-like sequences in the NOX4 locus bound by IRP1, which dissociates upon iron loading to derepress NOX4 transcription, linked NOX4 to iron-responsive gene regulation and ferroptosis in osteoblasts.","evidence":"IRP1 binding assay on NOX4 IRE-like sequences, Hepc1−/− iron overload mice, ferroptosis inhibitor rescue","pmids":["36738798"],"confidence":"Medium","gaps":["IRE-like elements not validated by reporter mutagenesis in independent labs","whether IRP1-NOX4 axis operates in non-bone tissues"]},{"year":2024,"claim":"ISG15-mediated ISGylation was identified as a post-translational stabilizer of NOX4 protein, with DRD4 activation counteracting this by promoting NOX4 ubiquitination and degradation, revealing a new layer of NOX4 protein turnover control.","evidence":"ISGylation and ubiquitination assays, ISG15 knockdown, DRD4 KO mice in IRI and cisplatin kidney injury models","pmids":["38354631"],"confidence":"Medium","gaps":["specific ISGylation sites on NOX4 not mapped","E3 ligase mediating NOX4 ubiquitination not identified","single-lab finding awaiting independent confirmation"]},{"year":null,"claim":"Despite extensive functional characterization, no high-resolution structure of NOX4 (alone or in complex with p22phox, GADD34, or CYB5R3) exists, and the precise molecular mechanism by which the dehydrogenase domain selectively produces H2O2 rather than superoxide remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["no cryo-EM or crystal structure of NOX4","structural basis for H2O2 selectivity unknown","complete inventory of direct oxidation substrates of NOX4-derived H2O2 not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,1,2,3,5,13,14,20]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[6,15,16]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[3,5,6]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[2,10,29]}],"pathway":[{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[6,9,21,32]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,15,36]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[20,34]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[7,10]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[26,27]}],"complexes":["NOX4–p22phox NADPH oxidase"],"partners":["CYBA","FYN","PPP1R15A","CYB5R3","CD44","PRKCA","TRPC6"],"other_free_text":[]},"mechanistic_narrative":"NOX4 is a constitutively active, p22phox-dependent NADPH oxidase that primarily generates H2O2 and functions as a redox signaling hub controlling cell survival, metabolic adaptation, and tissue homeostasis across diverse organs. Its cytosolic C-terminal domain confers constitutive catalytic activity, while the N-terminal region directs localization predominantly to the endoplasmic reticulum and ER–mitochondria contact sites, where it inhibits PP1 via GADD34-dependent metal-center oxidation to sustain eIF2α phosphorylation and ATF4-mediated survival, and suppresses calcium transfer through Akt-dependent InsP3R phosphorylation to prevent mitochondrial permeability transition [PMID:19061439, PMID:26742780, PMID:33001475]. NOX4-derived H2O2 activates the Nrf2/NFE2L2 antioxidant pathway to maintain redox homeostasis in cardiomyocytes, skeletal muscle, and hepatocytes, and also stabilizes HIF-1α/HIF-2α to drive angiogenic and glycolytic programs; it further inactivates protein tyrosine phosphatases to potentiate insulin and growth factor signaling through Akt and ERK [PMID:21554947, PMID:34910515, PMID:25467946, PMID:22328777]. NOX4 activity is negatively regulated by FYN-mediated phosphorylation at Y566 and by IP4 competing for the NADPH-binding site, while its expression is induced by TGF-β/Smad, STAT5, ATF4, and E2F pathways, and post-translationally stabilized by ISG15-mediated ISGylation [PMID:27525436, PMID:31081803, PMID:24259511, PMID:26308771, PMID:38354631]."},"prefetch_data":{"uniprot":{"accession":"Q9NPH5","full_name":"NADPH oxidase 4","aliases":["Kidney oxidase-1","KOX-1","Kidney superoxide-producing NADPH oxidase","Renal NAD(P)H-oxidase"],"length_aa":578,"mass_kda":66.9,"function":"NADPH oxidase that catalyzes predominantly the reduction of oxygen to H2O2 (PubMed:14966267, PubMed:15356101, PubMed:15927447, PubMed:21343298, PubMed:25062272). Can also catalyze to a smaller extent, the reduction of oxygen to superoxide (PubMed:10869423, PubMed:11032835, PubMed:15155719, PubMed:15572675, PubMed:15927447, PubMed:16019190, PubMed:16179589, PubMed:16230378, PubMed:16324151, PubMed:25062272). May function as an oxygen sensor regulating the KCNK3/TASK-1 potassium channel and HIF1A activity (PubMed:16019190). May regulate insulin signaling cascade (PubMed:14966267). May play a role in apoptosis, bone resorption and lipolysaccharide-mediated activation of NFKB (PubMed:15356101, PubMed:15572675). May produce superoxide in the nucleus and play a role in regulating gene expression upon cell stimulation (PubMed:16324151). Promotes ferroptosis, reactive oxygen species production and reduced glutathione (GSH) levels by activating NLRP3 inflammasome activation and cytokine release (PubMed:39909992) NADPH oxidase that catalyzes the generation of superoxide from molecular oxygen utilizing NADPH as an electron donor (PubMed:15721269, PubMed:23393389). Involved in redox signaling in vascular cells (PubMed:23393389). Modulates the nuclear activation of ERK1/2 and the ELK1 transcription factor, and is capable of inducing nuclear DNA damage (PubMed:23393389) Lacks superoxide-generating NADPH oxidase activity","subcellular_location":"Cytoplasm; Cytoplasm, perinuclear region","url":"https://www.uniprot.org/uniprotkb/Q9NPH5/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NOX4","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/NOX4","total_profiled":1310},"omim":[{"mim_id":"617509","title":"VON WILLEBRAND FACTOR A DOMAIN-CONTAINING PROTEIN 8; VWA8","url":"https://www.omim.org/entry/617509"},{"mim_id":"606255","title":"STATURE AS A QUANTITATIVE TRAIT","url":"https://www.omim.org/entry/606255"},{"mim_id":"605441","title":"ADIPOCYTE-, C1q-, AND COLLAGEN DOMAIN-CONTAINING; ADIPOQ","url":"https://www.omim.org/entry/605441"},{"mim_id":"605261","title":"NADPH OXIDASE 4; NOX4","url":"https://www.omim.org/entry/605261"},{"mim_id":"600524","title":"RYK RECEPTOR-LIKE TYROSINE KINASE; RYK","url":"https://www.omim.org/entry/600524"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"blood vessel","ntpm":35.3},{"tissue":"kidney","ntpm":128.9}],"url":"https://www.proteinatlas.org/search/NOX4"},"hgnc":{"alias_symbol":["KOX-1","KOX"],"prev_symbol":[]},"alphafold":{"accession":"Q9NPH5","domains":[{"cath_id":"-","chopping":"6-159_211-218_277-297","consensus_level":"high","plddt":91.6423,"start":6,"end":297},{"cath_id":"2.40.30.10","chopping":"309-387_404-414","consensus_level":"high","plddt":91.8128,"start":309,"end":414},{"cath_id":"3.40.50.80","chopping":"417-576","consensus_level":"high","plddt":92.9165,"start":417,"end":576}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NPH5","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NPH5-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NPH5-F1-predicted_aligned_error_v6.png","plddt_mean":87.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NOX4","jax_strain_url":"https://www.jax.org/strain/search?query=NOX4"},"sequence":{"accession":"Q9NPH5","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NPH5.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NPH5/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NPH5"}},"corpus_meta":[{"pmid":"16135519","id":"PMC_16135519","title":"Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16135519","citation_count":433,"is_preprint":false},{"pmid":"19706525","id":"PMC_19706525","title":"Subcellular localization of Nox4 and regulation in diabetes.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19706525","citation_count":403,"is_preprint":false},{"pmid":"15802177","id":"PMC_15802177","title":"Neuronal expression of the NADPH oxidase NOX4, and its regulation in mouse experimental brain ischemia.","date":"2005","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15802177","citation_count":237,"is_preprint":false},{"pmid":"12842860","id":"PMC_12842860","title":"Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells.","date":"2003","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12842860","citation_count":229,"is_preprint":false},{"pmid":"19057021","id":"PMC_19057021","title":"Nox4 acts as a switch between differentiation and proliferation in preadipocytes.","date":"2008","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19057021","citation_count":210,"is_preprint":false},{"pmid":"16987004","id":"PMC_16987004","title":"NOX2 and NOX4 mediate proliferative response in endothelial cells.","date":"2006","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/16987004","citation_count":206,"is_preprint":false},{"pmid":"28424170","id":"PMC_28424170","title":"ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria in VEGF signaling and angiogenesis.","date":"2017","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/28424170","citation_count":203,"is_preprint":false},{"pmid":"27576730","id":"PMC_27576730","title":"Metformin attenuates lung fibrosis development via NOX4 suppression.","date":"2016","source":"Respiratory research","url":"https://pubmed.ncbi.nlm.nih.gov/27576730","citation_count":181,"is_preprint":false},{"pmid":"21554947","id":"PMC_21554947","title":"Nox4 regulates Nrf2 and glutathione redox in cardiomyocytes in vivo.","date":"2011","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21554947","citation_count":150,"is_preprint":false},{"pmid":"26385958","id":"PMC_26385958","title":"The NADPH oxidase Nox4 has anti-atherosclerotic functions.","date":"2015","source":"European heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/26385958","citation_count":144,"is_preprint":false},{"pmid":"22904198","id":"PMC_22904198","title":"The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation.","date":"2012","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22904198","citation_count":132,"is_preprint":false},{"pmid":"19061439","id":"PMC_19061439","title":"Identification of structural elements in Nox1 and Nox4 controlling localization and activity.","date":"2009","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/19061439","citation_count":125,"is_preprint":false},{"pmid":"22937798","id":"PMC_22937798","title":"Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress.","date":"2012","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/22937798","citation_count":120,"is_preprint":false},{"pmid":"29793963","id":"PMC_29793963","title":"A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.","date":"2018","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/29793963","citation_count":116,"is_preprint":false},{"pmid":"31618425","id":"PMC_31618425","title":"miR-590-3p Inhibits Pyroptosis in Diabetic Retinopathy by Targeting NLRP1 and Inactivating the NOX4 Signaling Pathway.","date":"2019","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/31618425","citation_count":105,"is_preprint":false},{"pmid":"26742780","id":"PMC_26742780","title":"Targeted redox inhibition of protein phosphatase 1 by Nox4 regulates eIF2α-mediated stress signaling.","date":"2016","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/26742780","citation_count":101,"is_preprint":false},{"pmid":"25950600","id":"PMC_25950600","title":"The human Nox4: gene, structure, physiological function and pathological significance.","date":"2015","source":"Journal of drug targeting","url":"https://pubmed.ncbi.nlm.nih.gov/25950600","citation_count":90,"is_preprint":false},{"pmid":"24259511","id":"PMC_24259511","title":"Upregulation of mitochondrial Nox4 mediates TGF-β-induced apoptosis in cultured mouse podocytes.","date":"2013","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24259511","citation_count":90,"is_preprint":false},{"pmid":"35917680","id":"PMC_35917680","title":"TRPM7 channel inhibition attenuates rheumatoid arthritis articular chondrocyte ferroptosis by suppression of the PKCα-NOX4 axis.","date":"2022","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/35917680","citation_count":87,"is_preprint":false},{"pmid":"34910515","id":"PMC_34910515","title":"Skeletal muscle NOX4 is required for adaptive responses that prevent insulin resistance.","date":"2021","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/34910515","citation_count":81,"is_preprint":false},{"pmid":"28232723","id":"PMC_28232723","title":"Mutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28232723","citation_count":80,"is_preprint":false},{"pmid":"24509161","id":"PMC_24509161","title":"The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression.","date":"2014","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24509161","citation_count":79,"is_preprint":false},{"pmid":"33001475","id":"PMC_33001475","title":"Nox4 regulates InsP3 receptor-dependent Ca2+ release into mitochondria to promote cell survival.","date":"2020","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/33001475","citation_count":76,"is_preprint":false},{"pmid":"27525436","id":"PMC_27525436","title":"Tyrosine kinase FYN negatively regulates NOX4 in cardiac remodeling.","date":"2016","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/27525436","citation_count":74,"is_preprint":false},{"pmid":"18474828","id":"PMC_18474828","title":"Nox4 oxidase overexpression specifically decreases endogenous Nox4 mRNA and inhibits angiotensin II-induced adventitial myofibroblast migration.","date":"2008","source":"Hypertension (Dallas, Tex. : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/18474828","citation_count":72,"is_preprint":false},{"pmid":"27936392","id":"PMC_27936392","title":"Rutin protects endothelial dysfunction by disturbing Nox4 and ROS-sensitive NLRP3 inflammasome.","date":"2016","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/27936392","citation_count":71,"is_preprint":false},{"pmid":"37321060","id":"PMC_37321060","title":"Nox4 as a novel therapeutic target for diabetic vascular complications.","date":"2023","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/37321060","citation_count":68,"is_preprint":false},{"pmid":"34530693","id":"PMC_34530693","title":"Ursolic acid reverses liver fibrosis by inhibiting NOX4/NLRP3 inflammasome pathways and bacterial dysbiosis.","date":"2021","source":"Gut microbes","url":"https://pubmed.ncbi.nlm.nih.gov/34530693","citation_count":66,"is_preprint":false},{"pmid":"24847449","id":"PMC_24847449","title":"Role of the NADPH Oxidases DUOX and NOX4 in Thyroid Oxidative Stress.","date":"2013","source":"European thyroid journal","url":"https://pubmed.ncbi.nlm.nih.gov/24847449","citation_count":64,"is_preprint":false},{"pmid":"29040462","id":"PMC_29040462","title":"Both cardiomyocyte and endothelial cell Nox4 mediate protection against hemodynamic overload-induced remodelling.","date":"2018","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/29040462","citation_count":63,"is_preprint":false},{"pmid":"27941881","id":"PMC_27941881","title":"The NADPH oxidase NOX4 represses epithelial to amoeboid transition and efficient tumour dissemination.","date":"2016","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/27941881","citation_count":62,"is_preprint":false},{"pmid":"29496628","id":"PMC_29496628","title":"NOX4-driven ROS formation regulates proliferation and apoptosis of gastric cancer cells through the GLI1 pathway.","date":"2018","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/29496628","citation_count":61,"is_preprint":false},{"pmid":"30178632","id":"PMC_30178632","title":"A genome-wide association study suggests new evidence for an association of the NADPH Oxidase 4 (NOX4) gene with severe diabetic retinopathy in type 2 diabetes.","date":"2018","source":"Acta ophthalmologica","url":"https://pubmed.ncbi.nlm.nih.gov/30178632","citation_count":60,"is_preprint":false},{"pmid":"24755467","id":"PMC_24755467","title":"NADPH oxidase NOX4 supports renal tumorigenesis by promoting the expression and nuclear accumulation of HIF2α.","date":"2014","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/24755467","citation_count":58,"is_preprint":false},{"pmid":"32544088","id":"PMC_32544088","title":"Brd4-p300 inhibition downregulates Nox4 and accelerates lung fibrosis resolution in aged mice.","date":"2020","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/32544088","citation_count":57,"is_preprint":false},{"pmid":"35023280","id":"PMC_35023280","title":"Ferroptosis-related gene NOX4, CHAC1 and HIF1A are valid biomarkers for stomach adenocarcinoma.","date":"2022","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35023280","citation_count":56,"is_preprint":false},{"pmid":"34438016","id":"PMC_34438016","title":"Backstage players of fibrosis: NOX4, mTOR, HDAC, and S1P; companions of TGF-β.","date":"2021","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/34438016","citation_count":55,"is_preprint":false},{"pmid":"22328777","id":"PMC_22328777","title":"NOX4 pathway as a source of selective insulin resistance and responsiveness.","date":"2012","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22328777","citation_count":55,"is_preprint":false},{"pmid":"26308771","id":"PMC_26308771","title":"NOX4-driven ROS formation mediates PTP inactivation and cell transformation in FLT3ITD-positive AML cells.","date":"2015","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/26308771","citation_count":55,"is_preprint":false},{"pmid":"32641980","id":"PMC_32641980","title":"Oleic acid-induced NOX4 is dependent on ANGPTL4 expression to promote human colorectal cancer metastasis.","date":"2020","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/32641980","citation_count":54,"is_preprint":false},{"pmid":"27393154","id":"PMC_27393154","title":"mTORC2 Signaling Regulates Nox4-Induced Podocyte Depletion in Diabetes.","date":"2016","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/27393154","citation_count":53,"is_preprint":false},{"pmid":"21965295","id":"PMC_21965295","title":"NOX4 mediates activation of FoxO3a and matrix metalloproteinase-2 expression by urotensin-II.","date":"2011","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/21965295","citation_count":49,"is_preprint":false},{"pmid":"26513738","id":"PMC_26513738","title":"The NADPH Oxidase Nox4 mediates tumour angiogenesis.","date":"2015","source":"Acta physiologica (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/26513738","citation_count":49,"is_preprint":false},{"pmid":"36738798","id":"PMC_36738798","title":"Osteoporotic bone loss from excess iron accumulation is driven by NOX4-triggered ferroptosis in osteoblasts.","date":"2023","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36738798","citation_count":46,"is_preprint":false},{"pmid":"37871532","id":"PMC_37871532","title":"Cardiomyocyte NOX4 regulates resident macrophage-mediated inflammation and diastolic dysfunction in stress cardiomyopathy.","date":"2023","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/37871532","citation_count":44,"is_preprint":false},{"pmid":"26812119","id":"PMC_26812119","title":"Pro-atherogenic role of smooth muscle Nox4-based NADPH oxidase.","date":"2016","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/26812119","citation_count":44,"is_preprint":false},{"pmid":"23678045","id":"PMC_23678045","title":"ADAM17 mediates Nox4 expression and NADPH oxidase activity in the kidney cortex of OVE26 mice.","date":"2013","source":"American journal of physiology. Renal physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23678045","citation_count":44,"is_preprint":false},{"pmid":"8464732","id":"PMC_8464732","title":"Duplicated KOX zinc finger gene clusters flank the centromere of human chromosome 10: evidence for a pericentric inversion during primate evolution.","date":"1993","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/8464732","citation_count":42,"is_preprint":false},{"pmid":"31247506","id":"PMC_31247506","title":"Tubular NOX4 expression decreases in chronic kidney disease but does not modify fibrosis evolution.","date":"2019","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/31247506","citation_count":38,"is_preprint":false},{"pmid":"25402870","id":"PMC_25402870","title":"Nox-4 and progressive kidney disease.","date":"2015","source":"Current opinion in nephrology and hypertension","url":"https://pubmed.ncbi.nlm.nih.gov/25402870","citation_count":37,"is_preprint":false},{"pmid":"25652847","id":"PMC_25652847","title":"Nox4 supports proper capillary growth in exercise and retina neo-vascularization.","date":"2015","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25652847","citation_count":37,"is_preprint":false},{"pmid":"26582463","id":"PMC_26582463","title":"Role of smooth muscle Nox4-based NADPH oxidase in neointimal hyperplasia.","date":"2015","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/26582463","citation_count":37,"is_preprint":false},{"pmid":"32227122","id":"PMC_32227122","title":"Alamandine attenuates hepatic fibrosis by regulating autophagy induced by NOX4-dependent ROS.","date":"2020","source":"Clinical science (London, England : 1979)","url":"https://pubmed.ncbi.nlm.nih.gov/32227122","citation_count":37,"is_preprint":false},{"pmid":"29204124","id":"PMC_29204124","title":"Alternative Splicing of NOX4 in the Failing Human Heart.","date":"2017","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29204124","citation_count":37,"is_preprint":false},{"pmid":"35269843","id":"PMC_35269843","title":"NADPH Oxidase 4 (NOX4) in Cancer: Linking Redox Signals to Oncogenic Metabolic Adaptation.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35269843","citation_count":36,"is_preprint":false},{"pmid":"28594389","id":"PMC_28594389","title":"The Role of NOX4 and TRX2 in Angiogenesis and Their Potential Cross-Talk.","date":"2017","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/28594389","citation_count":35,"is_preprint":false},{"pmid":"35617030","id":"PMC_35617030","title":"Breast cancer chemotherapy induces vascular dysfunction and hypertension through a NOX4-dependent mechanism.","date":"2022","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/35617030","citation_count":35,"is_preprint":false},{"pmid":"31081803","id":"PMC_31081803","title":"Inositol-triphosphate 3-kinase B confers cisplatin resistance by regulating NOX4-dependent redox balance.","date":"2019","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/31081803","citation_count":35,"is_preprint":false},{"pmid":"29047077","id":"PMC_29047077","title":"Adventitial Fibroblast Nox4 Expression and ROS Signaling in Pulmonary Arterial Hypertension.","date":"2017","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/29047077","citation_count":34,"is_preprint":false},{"pmid":"32901890","id":"PMC_32901890","title":"Circular RNA NOX4 promotes the development of colorectal cancer via the microRNA‑485‑5p/CKS1B axis.","date":"2020","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/32901890","citation_count":34,"is_preprint":false},{"pmid":"30367082","id":"PMC_30367082","title":"NADPH oxidase NOX4 is a glycolytic regulator through mROS-HIF1α axis in thyroid carcinomas.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30367082","citation_count":34,"is_preprint":false},{"pmid":"36821829","id":"PMC_36821829","title":"Topically Administered NOX4 Inhibitor, GLX7013114, Is Efficacious in Treating the Early Pathological Events of Diabetic Retinopathy.","date":"2023","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/36821829","citation_count":34,"is_preprint":false},{"pmid":"38060313","id":"PMC_38060313","title":"Mitochondria- and NOX4-dependent antioxidant defense mitigates progression to nonalcoholic steatohepatitis in obesity.","date":"2023","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/38060313","citation_count":33,"is_preprint":false},{"pmid":"35920301","id":"PMC_35920301","title":"The NADPH oxidase NOX4 regulates redox and metabolic homeostasis preventing HCC progression.","date":"2022","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/35920301","citation_count":33,"is_preprint":false},{"pmid":"34650437","id":"PMC_34650437","title":"Nox4 Promotes RANKL-Induced Autophagy and Osteoclastogenesis via Activating ROS/PERK/eIF-2α/ATF4 Pathway.","date":"2021","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34650437","citation_count":33,"is_preprint":false},{"pmid":"37288723","id":"PMC_37288723","title":"Metformin ameliorates ferroptosis in cardiac ischemia and reperfusion by reducing NOX4 expression via promoting AMPKα.","date":"2023","source":"Pharmaceutical biology","url":"https://pubmed.ncbi.nlm.nih.gov/37288723","citation_count":32,"is_preprint":false},{"pmid":"32799394","id":"PMC_32799394","title":"NOX4-dependent regulation of ENaC in hypertension and diabetic kidney disease.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32799394","citation_count":32,"is_preprint":false},{"pmid":"21251215","id":"PMC_21251215","title":"Nox2 and Nox4 mediate tumour necrosis factor-α-induced ventricular remodelling in mice.","date":"2011","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21251215","citation_count":32,"is_preprint":false},{"pmid":"33010578","id":"PMC_33010578","title":"The correlation of IRE1α oxidation with Nox4 activation in aging-associated vascular dysfunction.","date":"2020","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/33010578","citation_count":31,"is_preprint":false},{"pmid":"35203105","id":"PMC_35203105","title":"NOX4 regulates TGFβ-induced proliferation and self-renewal in glioblastoma stem cells.","date":"2022","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35203105","citation_count":31,"is_preprint":false},{"pmid":"34435888","id":"PMC_34435888","title":"Role of Nox4 in High Calcium-Induced Renal Oxidative Stress Damage and Crystal Deposition.","date":"2021","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/34435888","citation_count":31,"is_preprint":false},{"pmid":"29336467","id":"PMC_29336467","title":"NOX4/ROS mediate ethanol‑induced apoptosis via MAPK signal pathway in L‑02 cells.","date":"2018","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29336467","citation_count":30,"is_preprint":false},{"pmid":"35035671","id":"PMC_35035671","title":"Forsythiaside A Regulates Activation of Hepatic Stellate Cells by Inhibiting NOX4-Dependent ROS.","date":"2022","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/35035671","citation_count":30,"is_preprint":false},{"pmid":"37061215","id":"PMC_37061215","title":"Targeting benign prostate hyperplasia treatments: AR/TGF-β/NOX4 inhibition by apocynin suppresses inflammation and proliferation.","date":"2023","source":"Journal of advanced research","url":"https://pubmed.ncbi.nlm.nih.gov/37061215","citation_count":29,"is_preprint":false},{"pmid":"34922273","id":"PMC_34922273","title":"Implication of type 4 NADPH oxidase (NOX4) in tauopathy.","date":"2021","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/34922273","citation_count":29,"is_preprint":false},{"pmid":"32666016","id":"PMC_32666016","title":"CSF-1 in Osteocytes Inhibits Nox4-mediated Oxidative Stress and Promotes Normal Bone Homeostasis.","date":"2019","source":"JBMR plus","url":"https://pubmed.ncbi.nlm.nih.gov/32666016","citation_count":28,"is_preprint":false},{"pmid":"34209278","id":"PMC_34209278","title":"NOX4 Signaling Mediates Cancer Development and Therapeutic Resistance through HER3 in Ovarian Cancer Cells.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34209278","citation_count":28,"is_preprint":false},{"pmid":"38844470","id":"PMC_38844470","title":"HOXD10 attenuates renal fibrosis by inhibiting NOX4-induced ferroptosis.","date":"2024","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/38844470","citation_count":27,"is_preprint":false},{"pmid":"29113787","id":"PMC_29113787","title":"Nox4 genetic inhibition in experimental hypertension and metabolic syndrome.","date":"2017","source":"Archives of cardiovascular diseases","url":"https://pubmed.ncbi.nlm.nih.gov/29113787","citation_count":27,"is_preprint":false},{"pmid":"32780450","id":"PMC_32780450","title":"The role of NOX4 in pulmonary diseases.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32780450","citation_count":26,"is_preprint":false},{"pmid":"34930338","id":"PMC_34930338","title":"NOX4: a potential therapeutic target for pancreatic cancer and its mechanism.","date":"2021","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34930338","citation_count":26,"is_preprint":false},{"pmid":"35524333","id":"PMC_35524333","title":"AIP1 suppresses neovascularization by inhibiting the NOX4-induced NLRP3/NLRP6 imbalance in a murine corneal alkali burn model.","date":"2022","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/35524333","citation_count":26,"is_preprint":false},{"pmid":"25410908","id":"PMC_25410908","title":"Nox4-mediated cell signaling regulates differentiation and survival of neural crest stem cells.","date":"2014","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/25410908","citation_count":26,"is_preprint":false},{"pmid":"27110716","id":"PMC_27110716","title":"Nox4 and Duox1/2 Mediate Redox Activation of Mesenchymal Cell Migration by PDGF.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27110716","citation_count":25,"is_preprint":false},{"pmid":"33836590","id":"PMC_33836590","title":"Genetic deletion of Nox4 enhances cancerogen-induced formation of solid tumors.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/33836590","citation_count":25,"is_preprint":false},{"pmid":"28423654","id":"PMC_28423654","title":"Mcl-1 regulates reactive oxygen species via NOX4 during chemotherapy-induced senescence.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/28423654","citation_count":25,"is_preprint":false},{"pmid":"32182821","id":"PMC_32182821","title":"Chronic Exposure to Fluoride Affects GSH Level and NOX4 Expression in Rat Model of This Element of Neurotoxicity.","date":"2020","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/32182821","citation_count":25,"is_preprint":false},{"pmid":"24868315","id":"PMC_24868315","title":"Lentivirus-mediated Nox4 shRNA invasion and angiogenesis and enhances radiosensitivity in human glioblastoma.","date":"2014","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/24868315","citation_count":24,"is_preprint":false},{"pmid":"30953402","id":"PMC_30953402","title":"Rutaecarpine prevents hypertensive cardiac hypertrophy involving the inhibition of Nox4-ROS-ADAM17 pathway.","date":"2018","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30953402","citation_count":24,"is_preprint":false},{"pmid":"35090586","id":"PMC_35090586","title":"Human iPSC model reveals a central role for NOX4 and oxidative stress in Duchenne cardiomyopathy.","date":"2022","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/35090586","citation_count":24,"is_preprint":false},{"pmid":"38483540","id":"PMC_38483540","title":"Myricetin Induces Ferroptosis and Inhibits Gastric Cancer Progression by Targeting NOX4.","date":"2024","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/38483540","citation_count":24,"is_preprint":false},{"pmid":"31661292","id":"PMC_31661292","title":"Unmasking the interplay between mTOR and Nox4: novel insights into the mechanism connecting diabetes and cancer.","date":"2019","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/31661292","citation_count":23,"is_preprint":false},{"pmid":"38227522","id":"PMC_38227522","title":"NADPH oxidase 4 (NOX4) as a biomarker and therapeutic target in neurodegenerative diseases.","date":"2023","source":"Neural regeneration research","url":"https://pubmed.ncbi.nlm.nih.gov/38227522","citation_count":22,"is_preprint":false},{"pmid":"38354631","id":"PMC_38354631","title":"DRD4 alleviates acute kidney injury by suppressing ISG15/NOX4 axis-associated oxidative stress.","date":"2024","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/38354631","citation_count":22,"is_preprint":false},{"pmid":"37119283","id":"PMC_37119283","title":"TRIM-containing 44 aggravates cardiac hypertrophy via TLR4/NOX4-induced ferroptosis.","date":"2023","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/37119283","citation_count":22,"is_preprint":false},{"pmid":"28099519","id":"PMC_28099519","title":"CRISPR-Cas9 Mediated NOX4 Knockout Inhibits Cell Proliferation and Invasion in HeLa Cells.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28099519","citation_count":22,"is_preprint":false},{"pmid":"33493901","id":"PMC_33493901","title":"NADPH oxidase 4 (Nox4) deletion accelerates liver regeneration in mice.","date":"2020","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/33493901","citation_count":22,"is_preprint":false},{"pmid":"8262519","id":"PMC_8262519","title":"Chromosomal localization of 9 KOX zinc finger genes: physical linkages suggest clustering of KOX genes on chromosomes 12, 16, and 19.","date":"1993","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8262519","citation_count":22,"is_preprint":false},{"pmid":"34656824","id":"PMC_34656824","title":"Cooperation between CYB5R3 and NOX4 via coenzyme Q mitigates endothelial inflammation.","date":"2021","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/34656824","citation_count":21,"is_preprint":false},{"pmid":"31419440","id":"PMC_31419440","title":"Tachycardia-induced CD44/NOX4 signaling is involved in the development of atrial remodeling.","date":"2019","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/31419440","citation_count":21,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54304,"output_tokens":9555,"usd":0.153118},"stage2":{"model":"claude-opus-4-6","input_tokens":13559,"output_tokens":4230,"usd":0.260317},"total_usd":0.413435,"stage1_batch_id":"msgbatch_012ZiiCUBfB62NCTQd4Bk1Jo","stage2_batch_id":"msgbatch_01Xuqq9aUHoQouS7UVGZNStZ","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"Nox4-based NADPH oxidase mediates angiotensin II-induced ROS generation and downstream Akt/PKB activation and protein synthesis in mesangial cells, acting downstream of Rac1 and arachidonic acid signaling\",\n      \"method\": \"Antisense oligonucleotide knockdown of Nox4, dominant-negative Rac1, NADPH oxidase activity assay, Akt phosphorylation measurement, protein synthesis assay\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (AS knockdown, DN-Rac1, functional assays) in single study\",\n      \"pmids\": [\"12842860\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Nox4 is the major source of NADPH-dependent ROS in diabetic kidney, and Nox4-derived ROS mediate renal hypertrophy and fibronectin expression via Akt/PKB and ERK1/2 activation\",\n      \"method\": \"Antisense oligonucleotide knockdown in vivo and in vitro, NADPH oxidase activity assay, glomerular hypertrophy measurement, fibronectin western blot, kinase phosphorylation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo and in vitro knockdown with multiple functional readouts, >400 citations indicating replication\",\n      \"pmids\": [\"16135519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Nox4 localizes to mitochondria in mesangial cells and kidney cortex, and mitochondrial Nox4 is a functional source of NADPH oxidase-dependent superoxide generation; siRNA knockdown of Nox4 reduces mitochondrial NADPH oxidase activity and blocks glucose-induced mitochondrial superoxide\",\n      \"method\": \"Subcellular fractionation, immunofluorescence confocal microscopy with MitoTracker, siRNA knockdown, NADPH oxidase activity assay in purified mitochondria\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal localization methods plus functional validation with siRNA\",\n      \"pmids\": [\"19706525\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The cytosolic tail of Nox4 confers constitutive activity, while the N-terminal region determines subcellular localization (ER vs. plasma membrane) and the type of ROS released (H2O2 vs. superoxide); Nox4 colocalizes with ER marker proteins\",\n      \"method\": \"Chimeric Nox1/Nox4 constructs expressed in HEK293 cells, TIRF microscopy, ROS measurement, N-terminal signal peptide swap experiments\",\n      \"journal\": \"Antioxidants & redox signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — domain-swap mutagenesis plus live-cell localization imaging with functional ROS output\",\n      \"pmids\": [\"19061439\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Nox4 acts as a switch from insulin-induced proliferation to differentiation in preadipocytes by controlling MAP kinase phosphatase-1 (MKP-1) expression, which limits ERK1/2 signaling; downregulation of Nox4 promotes ERK1/2-dependent proliferation and inhibits differentiation via IRS-1 phosphorylation at Ser612\",\n      \"method\": \"siRNA knockdown, Nox4 overexpression, MKP-1 siRNA and overexpression, ERK1/2 inhibition, IRS-1 phosphorylation assays in human and mouse preadipocytes\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain/loss-of-function with multiple pathway readouts in two cell types\",\n      \"pmids\": [\"19057021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"NOX4 interacts with p22phox (shown by bimolecular fluorescent complementation) and co-localizes with the endoplasmic reticulum marker calreticulin in endothelial cells; NOX4 contributes equally with NOX2 to endothelial ROS production and proliferation\",\n      \"method\": \"Bimolecular fluorescent complementation, colocalization with ER marker, siRNA knockdown, ROS measurement, proliferation assays\",\n      \"journal\": \"Antioxidants & redox signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — protein-protein interaction (BiFC) plus colocalization and functional knockdown\",\n      \"pmids\": [\"16987004\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Nox4 is induced downstream of ATF4, binds to the PP1-targeting subunit GADD34 at the endoplasmic reticulum, and inhibits PP1 via oxidation of the PP1 metal center (not thiol oxidation), thereby sustaining eIF2α phosphorylation and ATF4 levels to promote cell survival during stress\",\n      \"method\": \"Co-immunoprecipitation (Nox4–GADD34), PP1 activity assay, eIF2α phosphorylation measurement, mutagenesis, ER fractionation, heart ischemia-reperfusion and kidney injury in vivo models\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — biochemical reconstitution of PP1 inhibition mechanism, Co-IP, metal-center oxidation identified, in vivo validation\",\n      \"pmids\": [\"26742780\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Stress-induced Nox4 localizes to ER-mitochondria contact sites (MAMs) and inhibits calcium transfer through InsP3 receptors by augmenting Akt-dependent phosphorylation of InsP3R, thereby preventing mitochondrial permeability transition-dependent necrosis; limits infarct size in ischemia-reperfusion\",\n      \"method\": \"MAM fractionation, co-immunoprecipitation, InsP3R phosphorylation assay, calcium flux measurement, mPT assay, Nox4 KO mice, cardiomyocyte and neuron models\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal biochemical methods plus in vivo KO model\",\n      \"pmids\": [\"33001475\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"FYN tyrosine kinase interacts with the C-terminal domain of NOX4, co-localizes in perinuclear mitochondria/ER/nuclear fractions, and directly phosphorylates NOX4 at tyrosine 566 to negatively regulate NOX4-induced ROS production and apoptosis; FYN KO mice show exaggerated cardiac remodeling rescued by Nox4 deletion\",\n      \"method\": \"Co-immunoprecipitation, site-directed mutagenesis (Y566), ROS measurement, apoptosis assay, FYN KO and Nox4 KO epistasis in mice with transverse aortic constriction\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct phosphorylation site identified by mutagenesis, Co-IP, genetic epistasis in vivo\",\n      \"pmids\": [\"27525436\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Nox4 activates the Nrf2-regulated antioxidant pathway in cardiomyocytes, increasing expression of antioxidant/detoxifying genes and elevating GSH levels; these effects are abolished in an Nrf2-null genetic background\",\n      \"method\": \"Transgenic Nox4 overexpression in mouse heart, microarray transcriptomics, Q-PCR, GSH measurement, Nrf2 KO epistasis\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — transgenic OE plus Nrf2 KO epistasis with multiple molecular readouts\",\n      \"pmids\": [\"21554947\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TGF-β1-induced podocyte apoptosis is mediated by selective upregulation of Nox4 (localized to mitochondria) via TGF-β receptor I–Smad2/3 signaling, leading to ROS production, mitochondrial membrane potential loss, and caspase-3 activation\",\n      \"method\": \"siRNA knockdown (Nox4, Smad2, Smad3), TGF-β receptor inhibitor, Nox inhibitor DPI, mitochondrial membrane potential assay, caspase-3 activation assay, immunofluorescence\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple siRNA targets defining pathway, plus pharmacological inhibitors and localization\",\n      \"pmids\": [\"24259511\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NOX4 silencing in VHL-deficient renal cell carcinoma cells abrogates invasion, colony formation, and xenograft growth; NOX4 knockdown or superoxide scavenging blocks nuclear accumulation of HIF2α, establishing NOX4 as required for HIF2α nuclear localization and renal tumorigenesis\",\n      \"method\": \"siRNA knockdown, TEMPOL and catalase/MnSOD overexpression, xenograft model, HIF2α nuclear fractionation, cell invasion and colony assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic and pharmacological interventions, in vivo xenograft, mechanistic readout of HIF2α localization\",\n      \"pmids\": [\"24755467\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NOX4 promotes tumour angiogenesis by stabilizing HIF-1α and inducing VEGF-A, Glut1, and adrenomedullin expression; Nox4 knockout mice show 38% reduced tumour vessel density in fibrosarcoma model\",\n      \"method\": \"Nox4 KO mice (carcinogen-induced fibrosarcoma), CD31 immunostaining, Hif-1α and VEGF expression analysis\",\n      \"journal\": \"Acta physiologica (Oxford, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined angiogenic phenotype and molecular mechanism, but single study\",\n      \"pmids\": [\"26513738\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NOX4 in endothelial cells produces H2O2 rather than superoxide, and has anti-atherosclerotic function; endothelial-specific (but not macrophage) Nox4 deletion increases macrophage adhesion and atherosclerosis in ApoE-/- mice\",\n      \"method\": \"Tamoxifen-induced Nox4 KO crossed with ApoE-/- mice, cell-type-specific KO (endothelial vs. macrophage), atherosclerosis measurement, macrophage adhesion assay\",\n      \"journal\": \"European heart journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific KO with defined mechanistic readout; replicated across two atherosclerosis models\",\n      \"pmids\": [\"26385958\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Nox4-derived H2O2 activates Nox2 to increase mitochondrial ROS via p66Shc phosphorylation at Ser36, thereby enhancing VEGFR2 signaling and angiogenesis in endothelial cells (ROS-induced ROS release mechanism)\",\n      \"method\": \"Redox-sensitive RoGFP biosensors (cytosol- and mitochondria-targeted), siRNA knockdown of Nox4/Nox2, Nox4 overexpression, p66Shc(S36A) mutant, VEGFR2 phosphorylation assay, migration/proliferation assays\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — real-time biosensor imaging plus genetic and mutagenesis approaches defining the pathway\",\n      \"pmids\": [\"28424170\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NOX4-derived ROS inactivate protein tyrosine phosphatases (PTPs) and are required for all insulin signaling through AKT and ERK in hepatocytes; knockdown or inhibition of NOX4 reproduces the pattern of pathway-selective insulin resistance seen in diabetic db/db mice\",\n      \"method\": \"siRNA knockdown in cultured hepatocytes, pharmacological NOX4 inhibition, AKT Thr308/Ser473 phosphorylation assay, insulin injection in db/db mice\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knockdown recapitulates in vivo phenotype with multiple pathway readouts\",\n      \"pmids\": [\"22328777\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NOX4-driven ROS inactivate the protein tyrosine phosphatase DEP-1/PTPRJ in FLT3ITD-positive AML cells; NOX4 expression is driven by STAT5 transcriptional activation of the NOX4 promoter downstream of FLT3ITD, and NOX4 knockdown restores PTP activity and attenuates FLT3ITD-driven transformation\",\n      \"method\": \"NOX4 mRNA/protein measurement, STAT5 promoter activation assay, NOX4 knockdown, PTP activity assay, Nox4 KO hematopoietic progenitor transformation assay, in vivo mouse leukemia models\",\n      \"journal\": \"Leukemia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — PTP activity reconstitution, STAT5-promoter link, Nox4 KO epistasis in vitro and in vivo\",\n      \"pmids\": [\"26308771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Inositol 1,3,4,5-tetrakisphosphate (IP4), product of ITPKB, inhibits NOX4 by competing with NADPH for binding to NOX4, thereby reducing cisplatin-induced ROS and promoting cisplatin resistance\",\n      \"method\": \"ITPKB RNAi screen, IP4 competition binding assay with NADPH and NOX4, NOX4 activity assay, patient-derived xenografts, ITPKB inhibitor\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro competitive binding assay identifying IP4 as NOX4 cofactor competitor, plus in vivo PDX validation\",\n      \"pmids\": [\"31081803\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"TGF-β-induced NOX4 expression is required for SMAD phosphorylation and myofibroblast differentiation in lung fibroblasts; metformin activates AMPK to inhibit TGF-β-induced NOX4 expression, blocking fibrogenesis\",\n      \"method\": \"NOX4 siRNA knockdown, N-acetylcysteine, AMPK activation by metformin, SMAD phosphorylation assay, bleomycin-induced lung fibrosis mouse model\",\n      \"journal\": \"Respiratory research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — NOX4 siRNA places NOX4 upstream of SMAD signaling, confirmed in vivo\",\n      \"pmids\": [\"27576730\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"NOX4-derived H2O2 stimulates TRPC6-dependent calcium influx in podocytes; genetic ablation of Nox4 reduces basal intracellular Ca2+ and blunts angiotensin II-elicited calcium flux, protecting against diabetic kidney disease\",\n      \"method\": \"SSNox4-/- rats, TRPC6 KO and TRPC5/6 double-KO mice, live calcium imaging in freshly isolated glomeruli, H2O2 stimulation, electrophysiology, electron microscopy\",\n      \"journal\": \"Journal of the American Society of Nephrology : JASN\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple genetic KO models, live calcium biosensor imaging, electrophysiology\",\n      \"pmids\": [\"29793963\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"In PDAC, NOX4 activity accelerates oxidation of NADH and supports glycolysis by generating NAD+ for GAPDH-mediated glycolytic reactions; NOX4 is transcriptionally induced through p16-Rb-E2F pathway and requires p22phox (upregulated by KrasG12V-NF-κB) for its catalytic activity\",\n      \"method\": \"Gene expression profiling, NOX4 activity assay (NADH oxidation), p22phox Co-IP/expression, NF-κB reporter assay, E2F ChIP, glycolytic flux measurement in PDAC cell lines and patient specimens\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — biochemical activity assay defining NAD+ generation function, multiple regulatory pathway dissections\",\n      \"pmids\": [\"28232723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Skeletal muscle NOX4, induced by exercise, generates H2O2 that activates NFE2L2-mediated antioxidant defense; NOX4 deletion in skeletal muscle compromises antioxidant defense and causes insulin resistance in aging and obesity, which is corrected by GPX-1 deletion or NFE2L2 agonist\",\n      \"method\": \"Muscle-specific Nox4 KO mice, exercise testing, ROS measurement, NFE2L2 target gene expression, insulin tolerance, GPX-1 KO epistasis, NFE2L2 agonist treatment\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — tissue-specific KO with genetic epistasis (GPX-1 KO) and pharmacological rescue\",\n      \"pmids\": [\"34910515\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Nox4 promotes smooth muscle cell neointimal hyperplasia by upregulating thrombospondin 1 (TSP1), which drives SMC proliferation and migration; Nox4 dominant-negative mutation or siRNA knockdown reduces TSP1 expression and neointima formation after wire injury\",\n      \"method\": \"SM22α-driven Nox4 dominant-negative (P437H) transgenic mice, wire injury model, siRNA knockdown, TSP1 mRNA/protein, SMC proliferation and migration assays\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo transgenic model plus siRNA confirmation identifying TSP1 as downstream effector\",\n      \"pmids\": [\"26582463\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ADAM17 activation by hyperglycemia increases Nox4 expression and NADPH oxidase activity in kidney cortex, establishing Nox4 as downstream of ADAM17 in extracellular matrix accumulation in diabetic nephropathy\",\n      \"method\": \"ADAM17 inhibitor (TMI-005), ADAM17 siRNA, Nox4 expression and NADPH oxidase activity measurement, fibronectin/collagen expression in OVE26 diabetic mice and proximal tubular cells\",\n      \"journal\": \"American journal of physiology. Renal physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological and genetic inhibition places Nox4 downstream of ADAM17, single lab\",\n      \"pmids\": [\"23678045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NOX4-derived ROS suppress Rho GTPase (RhoC) and Cdc42 expression and downstream actomyosin contractility in hepatocellular carcinoma cells, maintaining epithelial characteristics and suppressing amoeboid invasion\",\n      \"method\": \"NOX4 siRNA knockdown and overexpression, Rho/Cdc42 expression, actomyosin contractility assay, 3D invasion assay, Nox4-deficient HCC patient correlation\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain/loss-of-function with defined molecular readouts, single lab\",\n      \"pmids\": [\"27941881\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"NOX4 and urotensin-II activate FoxO3a via NOX4-dependent JNK phosphorylation and 14-3-3 phosphorylation, reducing FoxO3a–14-3-3 interaction and enabling MMP-2 transcription to promote vascular smooth muscle cell proliferation and migration\",\n      \"method\": \"NOX4 siRNA, FoxO3a knockdown, FoxO3a-/- mice, MMP2 inhibitor, JNK phosphorylation, 14-3-3 co-immunoprecipitation\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO epistasis plus Co-IP defining mechanism, multiple orthogonal approaches\",\n      \"pmids\": [\"21965295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NOX4 upregulation by RANKL activates ROS/PERK/eIF-2α/ATF4 pathway to promote autophagy and osteoclastogenesis; Nox4 inhibition or shRNA knockdown attenuates RANKL-induced autophagy and osteoclast formation\",\n      \"method\": \"Nox4 shRNA, 5-O-methyl quercetin Nox4 inhibitor, PERK inhibitor (GSK2606414), ROS scavenger, ATF4/eIF-2α phosphorylation assay, autophagy measurement, osteoclastogenesis assay\",\n      \"journal\": \"Frontiers in pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple inhibitors and shRNA defining pathway; single lab\",\n      \"pmids\": [\"34650437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NOX4 global or neuronal knockdown in mice reduces pathological tau accumulation and improves macroautophagy flux via the autophagy-lysosomal pathway, preventing cognitive decline in a tauopathy model\",\n      \"method\": \"Global Nox4 KO, neuronal-targeted Nox4 shRNA (AAV-TauP301L model), autophagy flux measurement, tau immunostaining, cognitive behavioral testing\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — two genetic approaches (KO and neuron-specific KD) with functional epistasis and in vivo cognitive readout\",\n      \"pmids\": [\"34922273\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Tachypacing-induced CD44 signaling directly associates with NOX4 (co-immunoprecipitation documented), increasing NOX4 expression and oxidative stress leading to CaMKII oxidation and ryanodine receptor phosphorylation, contributing to atrial fibrillation\",\n      \"method\": \"Co-immunoprecipitation (CD44–NOX4), HAS/HA/CD44 pathway blockade, CD44-/- mice, Ca2+ spark measurement, ox-CaMKII and p-RyR2 assays\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP plus CD44 KO mice with functional calcium readouts; single lab\",\n      \"pmids\": [\"31419440\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CYB5R3 interacts with NOX4 at the mitochondrial outer membrane (confirmed by APEX2-EM, proximity ligation, and Co-localization by super-resolution microscopy), and CYB5R3 activity and membrane translocation are required for optimal H2O2 generation by NOX4 via coenzyme Q; endothelial CYB5R3 loss exacerbates NOX4-dependent inflammatory activation\",\n      \"method\": \"APEX2-based electron microscopy, proximity biotinylation, proximity ligation assay, super-resolution confocal microscopy, Cyb5r3 KO mice, siRNA double-knockdown (CYB5R3+NOX4), COQ6 KO cells\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple structural/proximity methods establishing protein interaction plus genetic epistasis defining functional consequence\",\n      \"pmids\": [\"34656824\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PKCα directly binds NOX4 and mediates TRPM7-dependent chondrocyte ferroptosis; TRPM7 channel inhibition reduces intracellular Ca2+, suppresses PKCα-NOX4 interaction, and attenuates ferroptosis in rheumatoid arthritis chondrocytes\",\n      \"method\": \"Co-immunoprecipitation (PKCα–NOX4), TRPM7 knockdown/pharmacological inhibition, calcium imaging, ferroptosis markers (MDA, lipid ROS), AA-rat model, AAV9-TRPM7 silencing\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — Co-IP identifying PKCα as NOX4 binding partner, plus in vivo AAV gene silencing; single lab\",\n      \"pmids\": [\"35917680\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"NOX4 locus contains IRE-like sequences bound and repressed by IRP1; iron loading induces IRP1 dissociation from these sequences, activating NOX4 transcription and increasing lipid peroxidation and ferroptosis in osteoblasts, contributing to osteoporotic bone loss\",\n      \"method\": \"IRE-like sequence identification in NOX4 locus, IRP1 binding/dissociation assay, iron overload mouse model (Hepc1-/-), ferroptosis inhibitor (Ferr-1), iron chelator (DFO), mitochondrial morphology by electron microscopy\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — identifies novel transcriptional regulatory element with functional in vivo validation; single study\",\n      \"pmids\": [\"36738798\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Mitochondria-derived ROS activate NFE2L2 which induces NOX4 expression; NOX4-derived H2O2 further amplifies NFE2L2 antioxidant defense; hepatocyte-specific NOX4 deletion reduces antioxidant defense and promotes NASH and fibrosis in obese mice\",\n      \"method\": \"Hepatocyte-specific Nox4 KO, Nox4 overexpression, ROS measurement, NFE2L2 target gene expression, NASH scoring, mitochondrial ROS imaging\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — tissue-specific KO with overexpression rescue, multiple molecular and histological readouts\",\n      \"pmids\": [\"38060313\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"NOX4 deletion in HCC leads to Nrf2 activation that upregulates MYC, which drives mitochondrial dynamics and metabolic reprogramming (increased oxidative metabolism, glycolysis, fatty acid use) to promote HCC progression\",\n      \"method\": \"Cell-based NOX4 loss/gain of function, proteomics, transcriptomics, metabolomics, in vivo hepatocarcinogenesis in Nox4-deficient mice, human HCC sample analysis\",\n      \"journal\": \"Hepatology (Baltimore, Md.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multi-omics in complementary experimental models with in vivo validation\",\n      \"pmids\": [\"35920301\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"NOX4 promotes glycolysis in thyroid carcinoma via the mROS–HIF1α axis; NOX4 knockdown and p22phox knockout both abolish mitochondrial ROS increase and destabilize HIF1α in hypoxia, reducing glycolysis and cell growth\",\n      \"method\": \"NOX4 siRNA knockdown, p22phox CRISPR KO, mROS measurement, HIF1α stability assay, glycolytic flux measurement\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — two complementary genetic approaches defining pathway; single lab\",\n      \"pmids\": [\"30367082\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ISG15 promotes NOX4 ISGylation to stabilize the protein; DRD4 activation reduces ISG15 expression, enhancing NOX4 ubiquitination and degradation, thereby counteracting oxidative stress-induced acute kidney injury\",\n      \"method\": \"Transcriptome sequencing, ISG15 knockdown, ISGylation and ubiquitination assays for NOX4, DRD4 KO mice (IRI and cisplatin models), HK-2 cell oxidative stress\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — identifies ISGylation as NOX4 stability mechanism with genetic in vivo validation; single lab\",\n      \"pmids\": [\"38354631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Nox4 regulates PDGF-induced mesenchymal cell migration by generating H2O2 that activates PKB/Akt (but not Erk1/2) via the PI3-kinase pathway; Nox4 siRNA knockdown reduces PDGF-stimulated H2O2, PKB/Akt phosphorylation, and migration in MSC\",\n      \"method\": \"Nox4 siRNA, real-time H2O2 measurement, PKB/Akt and Erk1/2 phosphorylation assays, migration assay in 3T3 fibroblasts and MSC\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA knockdown with pathway-specific phosphorylation readouts; single lab\",\n      \"pmids\": [\"27110716\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"NOX4-derived ROS activate GLI1 (Hedgehog pathway transcription factor) to promote gastric cancer cell proliferation; DPI (ROS inhibitor) and NOX4 knockdown reduce GLI1 expression, and GLI1 overexpression rescues proliferation in NOX4-knockdown cells\",\n      \"method\": \"NOX4 siRNA, DPI treatment, GLI1 overexpression rescue, proliferation assay, western blot for Cyclin D1/BAX\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — rescue experiment linking NOX4-ROS to GLI1; single lab\",\n      \"pmids\": [\"29496628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NOX4-derived ROS regulates epithelial Na+ channel (ENaC) activity in the cortical collecting duct; H2O2 upregulates ENaC, and genetic ablation of Nox4 in Dahl salt-sensitive rats attenuates high-salt-induced ENaC activity increase\",\n      \"method\": \"SSNox4-/- rat model, electrophysiology (ENaC patch-clamp), H2O2 stimulation, renal H2O2 production measurement\",\n      \"journal\": \"FASEB journal : official publication of the Federation of American Societies for Experimental Biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with functional electrophysiology; single lab\",\n      \"pmids\": [\"32799394\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"In cardiomyocytes, Nox4 is activated downstream of mTORC2/Rictor; siRNA knockdown of Rictor decreases Nox4 and NADPH oxidase activity, restoring podocin levels and reducing podocyte apoptosis in diabetic models\",\n      \"method\": \"Rictor siRNA and antisense oligonucleotides, Nox4 expression and NADPH oxidase activity, podocin measurement, apoptosis assay, OVE26 diabetic mouse model\",\n      \"journal\": \"Antioxidants & redox signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis placing mTORC2 upstream of Nox4; in vitro and in vivo\",\n      \"pmids\": [\"27393154\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NOX4 is a constitutively active, p22phox-dependent NADPH oxidase that localizes primarily to the endoplasmic reticulum (and to ER-mitochondria contact sites and mitochondria in some contexts) and uniquely produces H2O2 rather than superoxide; it regulates diverse cellular processes including survival signaling (via PP1 inhibition at GADD34/ER, Akt-dependent InsP3R phosphorylation at MAMs, and Nrf2-GSH pathway), transcription factor activity (HIF2α nuclear accumulation, FoxO3a, GLI1), ion channel regulation (ENaC, TRPC6-dependent Ca2+ influx), and metabolic adaptation (NAD+ regeneration for glycolysis, NFE2L2-antioxidant defense); its activity is negatively regulated by FYN-mediated tyrosine phosphorylation at Y566 and by IP4 competing for the NADPH binding site, and positively regulated by mTORC2, STAT5, TGF-β/Smad, and iron-responsive IRP1 dissociation from NOX4 promoter IRE-like elements.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"NOX4 is a constitutively active, p22phox-dependent NADPH oxidase that primarily generates H2O2 and functions as a redox signaling hub controlling cell survival, metabolic adaptation, and tissue homeostasis across diverse organs. Its cytosolic C-terminal domain confers constitutive catalytic activity, while the N-terminal region directs localization predominantly to the endoplasmic reticulum and ER–mitochondria contact sites, where it inhibits PP1 via GADD34-dependent metal-center oxidation to sustain eIF2α phosphorylation and ATF4-mediated survival, and suppresses calcium transfer through Akt-dependent InsP3R phosphorylation to prevent mitochondrial permeability transition [PMID:19061439, PMID:26742780, PMID:33001475]. NOX4-derived H2O2 activates the Nrf2/NFE2L2 antioxidant pathway to maintain redox homeostasis in cardiomyocytes, skeletal muscle, and hepatocytes, and also stabilizes HIF-1α/HIF-2α to drive angiogenic and glycolytic programs; it further inactivates protein tyrosine phosphatases to potentiate insulin and growth factor signaling through Akt and ERK [PMID:21554947, PMID:34910515, PMID:25467946, PMID:22328777]. NOX4 activity is negatively regulated by FYN-mediated phosphorylation at Y566 and by IP4 competing for the NADPH-binding site, while its expression is induced by TGF-β/Smad, STAT5, ATF4, and E2F pathways, and post-translationally stabilized by ISG15-mediated ISGylation [PMID:27525436, PMID:31081803, PMID:24259511, PMID:26308771, PMID:38354631].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Establishing NOX4 as a functional NADPH oxidase in non-phagocytic cells resolved the question of which oxidase generates angiotensin II-induced ROS in mesangial cells, linking it to Akt/PKB activation and protein synthesis.\",\n      \"evidence\": \"Antisense oligonucleotide knockdown of Nox4 with dominant-negative Rac1 in mesangial cells\",\n      \"pmids\": [\"12842860\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Rac1 dependence later contested for NOX4\", \"no structural basis for constitutive activity\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrating that Nox4 is the major renal NADPH oxidase in diabetic kidney established it as a disease-relevant ROS source mediating hypertrophy and fibrosis via Akt and ERK1/2.\",\n      \"evidence\": \"In vivo and in vitro antisense knockdown in diabetic mouse kidney with functional readouts\",\n      \"pmids\": [\"16135519\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"mechanism of Nox4 transcriptional induction in diabetes not defined\", \"specificity of antisense oligonucleotides\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Visualization of the NOX4–p22phox interaction and ER colocalization established that NOX4 forms a heterodimeric oxidase at the endoplasmic reticulum rather than the plasma membrane.\",\n      \"evidence\": \"Bimolecular fluorescent complementation with ER marker colocalization in endothelial cells\",\n      \"pmids\": [\"16987004\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"stoichiometry of NOX4–p22phox complex unresolved\", \"no structural model of the heterodimer\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Domain-swap chimeras between Nox1 and Nox4 revealed that the C-terminal dehydrogenase domain confers constitutive activity and H2O2 (rather than superoxide) production, while the N-terminus dictates subcellular targeting, resolving how NOX4 differs functionally from other NOX isoforms.\",\n      \"evidence\": \"Chimeric Nox1/Nox4 constructs in HEK293 cells with TIRF microscopy and ROS measurement; separately, mitochondrial localization confirmed by subcellular fractionation and confocal microscopy in mesangial cells\",\n      \"pmids\": [\"19061439\", \"19706525\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"structural basis for H2O2 vs. superoxide selectivity unclear\", \"whether mitochondrial localization reflects outer membrane vs. matrix association\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Identification of NOX4 as an activator of the Nrf2 antioxidant pathway in cardiomyocytes and of FoxO3a via JNK-dependent 14-3-3 phosphorylation in vascular smooth muscle revealed that NOX4-derived ROS engage specific transcription factor circuits rather than causing indiscriminate oxidative damage.\",\n      \"evidence\": \"Transgenic Nox4 overexpression with Nrf2 KO epistasis in mouse heart; NOX4 siRNA with FoxO3a KO mice and JNK/14-3-3 Co-IP in VSMCs\",\n      \"pmids\": [\"21554947\", \"21965295\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"direct oxidative target linking NOX4 to Nrf2 activation not identified\", \"whether FoxO3a regulation is cell-type-specific\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"A series of studies established NOX4's dual role in cancer and vascular biology: NOX4-derived ROS stabilize HIF-1α/HIF-2α to promote tumor angiogenesis and renal carcinoma, inactivate protein tyrosine phosphatases to potentiate insulin signaling in hepatocytes, and confer anti-atherosclerotic protection in endothelial cells, demonstrating context-dependent pro- and anti-pathological functions.\",\n      \"evidence\": \"Endothelial-specific Nox4 KO in ApoE−/− mice; NOX4 siRNA in VHL-deficient RCC with xenograft; Nox4 KO in carcinogen-induced fibrosarcoma; NOX4 knockdown in hepatocytes with insulin signaling readout; STAT5-driven NOX4 expression in FLT3-ITD AML\",\n      \"pmids\": [\"26385958\", \"24755467\", \"26513738\", \"22328777\", \"26308771\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"molecular identity of the oxidized PTPs varies by cell context and is incompletely catalogued\", \"mechanism of HIF-2α nuclear import regulation by ROS unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Discovery that NOX4 binds GADD34 at the ER and inhibits PP1 via oxidation of the PP1 metal center (not cysteine thiols) provided the first direct enzymatic substrate mechanism for NOX4-derived H2O2, explaining how it sustains eIF2α phosphorylation and ATF4-dependent survival during stress.\",\n      \"evidence\": \"Co-immunoprecipitation of Nox4–GADD34, PP1 activity assay with metal-center oxidation mechanism, in vivo ischemia-reperfusion models\",\n      \"pmids\": [\"26742780\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"whether metal-center oxidation generalizes to other PP1 holoenzyme contexts\", \"no crystal structure of NOX4–GADD34–PP1 ternary complex\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identification of FYN as a direct NOX4 kinase at Y566 that negatively regulates ROS production, with genetic epistasis in FYN KO/Nox4 KO mice, established the first post-translational negative regulatory mechanism for NOX4 catalytic output.\",\n      \"evidence\": \"Co-IP, Y566 site-directed mutagenesis, FYN KO and Nox4 KO epistasis in transverse aortic constriction model\",\n      \"pmids\": [\"27525436\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"whether other Src-family kinases also phosphorylate Y566\", \"structural consequence of Y566 phosphorylation on dehydrogenase domain\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstration that NOX4 oxidizes NADH to regenerate NAD+ for GAPDH-dependent glycolysis in pancreatic cancer revealed an unexpected metabolic function beyond canonical ROS signaling, with transcriptional regulation through p16-Rb-E2F and p22phox upregulation via KrasG12V–NF-κB.\",\n      \"evidence\": \"NADH oxidation assay, glycolytic flux measurement, E2F ChIP, p22phox Co-IP in PDAC cell lines and patient specimens\",\n      \"pmids\": [\"28232723\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"relative contribution of NAD+ regeneration vs. H2O2 signaling to PDAC phenotype unclear\", \"whether NOX4-mediated NAD+ regeneration operates in non-cancer contexts\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"NOX4-derived H2O2 was shown to activate TRPC6-dependent calcium influx in podocytes, defining a non-transcriptional ion-channel regulatory function of NOX4 relevant to diabetic kidney disease.\",\n      \"evidence\": \"SSNox4−/− rats combined with TRPC6 KO and TRPC5/6 double-KO mice, live calcium imaging, electrophysiology\",\n      \"pmids\": [\"29793963\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"direct molecular target on TRPC6 oxidized by H2O2 not identified\", \"whether ENaC regulation (separately shown) involves the same mechanism\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Discovery that IP4 inhibits NOX4 by competing with NADPH for its binding site identified a novel endogenous small-molecule mechanism for NOX4 regulation and explained ITPKB-dependent cisplatin resistance.\",\n      \"evidence\": \"In vitro competitive binding assay (IP4 vs. NADPH on NOX4), patient-derived xenografts, ITPKB inhibitor\",\n      \"pmids\": [\"31081803\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"structural basis for IP4–NADPH competition not resolved\", \"whether other inositol phosphates also regulate NOX4\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Localization of stress-induced NOX4 to ER–mitochondria contact sites (MAMs) and demonstration that it inhibits InsP3R-mediated calcium transfer via Akt-dependent phosphorylation established a cytoprotective mechanism at the ER–mitochondria interface limiting necrotic cell death.\",\n      \"evidence\": \"MAM fractionation, InsP3R phosphorylation assay, calcium flux measurement, mPT assay, Nox4 KO mice in ischemia-reperfusion\",\n      \"pmids\": [\"33001475\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"how NOX4 is specifically recruited to MAMs under stress is unknown\", \"which Akt isoform mediates InsP3R phosphorylation downstream of NOX4\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Tissue-specific knockout studies in skeletal muscle and hepatocytes, combined with CYB5R3 interaction mapping, revealed that NOX4 is a central node in the NFE2L2-mediated antioxidant defense that prevents insulin resistance and NASH, and that CYB5R3 cooperates with NOX4 at the mitochondrial outer membrane via coenzyme Q for optimal H2O2 generation.\",\n      \"evidence\": \"Muscle-specific and hepatocyte-specific Nox4 KO mice, GPX-1 KO epistasis, NFE2L2 agonist rescue; APEX2-EM, proximity ligation, super-resolution microscopy for CYB5R3–NOX4 interaction, Cyb5r3 KO mice\",\n      \"pmids\": [\"34910515\", \"38060313\", \"34656824\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"whether CYB5R3 donates electrons directly to NOX4 or acts indirectly through CoQ pool\", \"mechanism by which NOX4-derived H2O2 activates NFE2L2 (direct Keap1 oxidation vs. intermediary)\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identification of IRE-like sequences in the NOX4 locus bound by IRP1, which dissociates upon iron loading to derepress NOX4 transcription, linked NOX4 to iron-responsive gene regulation and ferroptosis in osteoblasts.\",\n      \"evidence\": \"IRP1 binding assay on NOX4 IRE-like sequences, Hepc1−/− iron overload mice, ferroptosis inhibitor rescue\",\n      \"pmids\": [\"36738798\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"IRE-like elements not validated by reporter mutagenesis in independent labs\", \"whether IRP1-NOX4 axis operates in non-bone tissues\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"ISG15-mediated ISGylation was identified as a post-translational stabilizer of NOX4 protein, with DRD4 activation counteracting this by promoting NOX4 ubiquitination and degradation, revealing a new layer of NOX4 protein turnover control.\",\n      \"evidence\": \"ISGylation and ubiquitination assays, ISG15 knockdown, DRD4 KO mice in IRI and cisplatin kidney injury models\",\n      \"pmids\": [\"38354631\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"specific ISGylation sites on NOX4 not mapped\", \"E3 ligase mediating NOX4 ubiquitination not identified\", \"single-lab finding awaiting independent confirmation\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Despite extensive functional characterization, no high-resolution structure of NOX4 (alone or in complex with p22phox, GADD34, or CYB5R3) exists, and the precise molecular mechanism by which the dehydrogenase domain selectively produces H2O2 rather than superoxide remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"no cryo-EM or crystal structure of NOX4\", \"structural basis for H2O2 selectivity unknown\", \"complete inventory of direct oxidation substrates of NOX4-derived H2O2 not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 1, 2, 3, 5, 13, 14, 20]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [6, 15, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [3, 5, 6]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [2, 10, 29]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [6, 9, 21, 32]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 15, 36]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [20, 34]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [7, 10]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [26, 27]}\n    ],\n    \"complexes\": [\n      \"NOX4–p22phox NADPH oxidase\"\n    ],\n    \"partners\": [\n      \"CYBA\",\n      \"FYN\",\n      \"PPP1R15A\",\n      \"CYB5R3\",\n      \"CD44\",\n      \"PRKCA\",\n      \"TRPC6\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}